In a new Yale-led study, investigators have revealed previously unknown factors that contribute to the hardening of arteries and plaque growth, which cause heart disease. Their insight is the basis for a promising therapeutic approach to halt and potentially reverse plaque buildup and the progression of disease, the researchers said.
The study was published online by Nature Metabolism.
Current treatments for plaque and hardened arteries, a condition known as atherosclerosis, can slow but not improve the disease. Experts believe that may be due to ongoing inflammation in blood vessels. To understand the factors contributing to this inflammation, the research team focused on a group of proteins, called transforming growth factor beta (TGFß), that regulates a wide range of cells and tissues throughout the body.
Using cultured human cells, the researchers discovered that TGF? proteins trigger inflammation in endothelial cells — the cells that form the inner lining of artery walls — but not in other cell types. With a technique called single cell RNA-seq analysis, which measures the expression of every gene in single cells, they then showed that TGF? induced inflammation in these cells in mouse models. This finding was notable, said the researchers, because TGF? proteins are known to decrease inflammation in other cells in the body.
The researchers also showed that when the TGF? receptor gene is deleted in endothelial cells, both the inflammation and plaque in blood vessels are significantly reduced.
To test this approach as a potential therapy, the team, led by professor of medicine Michael Simons, M.D., used an “interfering” RNA, or RNAi, drug developed at Yale, to disrupt TGFß receptors. Interfering RNA use a gene’s own DNA sequence to turn off or silence the gene. To deliver the drug only to endothelial cells in the blood vessel walls of mice, they employed microscopic particles, or nanoparticles, created by their co-authors at MIT. This strategy reduced inflammation and plaque as effectively as the genetic technique.
The findings identify TGFß signaling as a major cause of chronic vessel wall inflammation, and demonstrate that disruption of this pathway leads to cessation of inflammation and substantial regression of existing plaque, said the scientists.
Based on this discovery, investigators at Yale and MIT have launched a biotech company, VasoRX, Inc., to develop this targeted approach, using the RNAi drug delivered by nanoparticles as a potential therapy for atherosclerosis in people.
Learn more: Yale-led study offers promising approach to reducing plaque in arteries
The Latest on: Atherosclerosis
[google_news title=”” keyword=”atherosclerosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Atherosclerosis
- Do you have chronic fatigue syndrome? Here’s how it impacts heart healthon May 12, 2024 at 3:30 am
Chronic Fatigue Syndrome (CFS), or myalgic encephalomyelitis, causes persistent fatigue and autonomic dysfunction. It leads to inflammation, oxidative stress, and cardiovascular risks like Heart ...
- ‘I'm a Cardiologist and This Is the Type of Fruit I Eat Almost Every Day for Heart Health’on May 11, 2024 at 4:25 pm
“Diet is one of the most modifiable risk factors for heart disease,” says Dr. Joy Gelbman, MD, a cardiologist at Weill Cornell Medicine. While heart disease is the number one cause of death in the U.S ...
- Arsenic in Community Water Raises Type 2 Diabetes Riskon May 9, 2024 at 4:59 pm
This study relied on two cohorts — the Strong Heart Family Study (SHFS) and the Multi-Ethnic Study of Atherosclerosis (MESA) — to elucidate the prospective association between T2D and arsenic levels ...
- Atherosclerosis Progression May Share Traits With Tumor Growthon May 7, 2024 at 5:00 pm
The progression of atherosclerosis, at a cellular level, is reminiscent of the processes involved in tumor growth, new research confirms. Importantly, the idea itself is not new—but until now, the ...
- Clogged arteries worsened by cells that behave like cancer cellson May 1, 2024 at 5:35 pm
Researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.
- New study reveals cancer-like features in atherosclerosison April 30, 2024 at 11:22 am
LOS ANGELES, April 30 (Xinhua) -- U.S. researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits ...
- Scientists find cancer-like features in atherosclerosis, spurring opportunity for new treatment approacheson April 30, 2024 at 6:18 am
Researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits similar to cancer that worsen the ...
- Highlights in Atherosclerosis and Lipid Management From ACC 2024on April 29, 2024 at 2:07 pm
Lipid highlights from ACC 2024 included positive outcomes for bempedoic acid in statin-intolerant patients and for an inclisiran-first strategy in those with atherosclerosis.
- Abatacept may decelerate progression of atherosclerosis in RA patients with CVD: Studyon April 28, 2024 at 8:00 pm
Researchers have found that abatacept treatment may benefit patients with rheumatoid arthritis (RA) who have a high risk of cardiovascular disease, according to a study published in ...
- Vitamins by Conditionon March 10, 2024 at 11:00 am
Considering taking supplements to treat atherosclerosis? Below is a list of common natural remedies used to treat or reduce the symptoms of atherosclerosis. Follow the links to read common uses ...
via Bing News